Keyphrases
Type 2 Diabetic Patients
100%
Liraglutide
100%
Body Weight Regulation
100%
Retrospective Database Study
100%
Continuer
66%
Hemoglobin A1c (HbA1c)
50%
Israel
16%
First Year
16%
Randomized Controlled Trial
16%
Maccabi Healthcare Services
16%
Healthcare
16%
Propensity Score Matching
16%
Adult Patients
16%
Confounding Factors
16%
Glycated Hemoglobin A1c
16%
Body Weight Reduction
16%
Novo Nordisk
16%
Body Weight Changes
16%
High Insulin
16%
Real-life Setting
16%
Glucose-lowering Drugs
16%
Continuation Treatment
16%
Diabetes Medications
16%
Persistent Use
16%
Medicine and Dentistry
Patient with Type 2 Diabetes
100%
Glycemic
100%
Liraglutide
100%
Body Weight Control
100%
Hemoglobin A1c
66%
Body Weight
50%
Glycated Hemoglobin
16%
Randomized Controlled Trial
16%
Diabetes
16%
Drug Therapy
16%
Health Care
16%
Retrospective Study
16%
Body Weight Change
16%
Propensity Score Matching
16%
Nursing and Health Professions
Patient with Type 2 Diabetes
100%
Liraglutide
100%
Body Weight Control
100%
Hemoglobin A1c
66%
Body Weight
50%
Health Service
33%
Glycosylated Hemoglobin
16%
Drug Therapy
16%
Confounding Factor
16%
Propensity Score
16%
Body Weight Change
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Liraglutide
100%
Hemoglobin A1c
66%
Glycosylated Hemoglobin
16%
Randomized Controlled Trial
16%
Retrospective Study
16%